BMRC
Bank of Marin Bancorp
BMRC has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
BMRC Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
BMRC's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like BMRC.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
BMRC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 6.8x | $28.52 | — |
| Cheap | 8.8x | $37.00 | +30% |
| Forward | 11x | $28.52 | — |
| Fair | 14x | $57.55 | +102% |
| Expensive | 18x | $75.08 | +163% |
Historical ranges are pointers, not guarantees.
BMRC has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
BMRC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BMRC, with profitability improving.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over BMRC on the outlook, with more favorable valuation expectations.
BMRC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.50 | -41% |
| Q3 2026 | $4.22 | +581% |
| Q2 2026 | $4.07 | +847% |
| Q1 2026 | $2.96 | +$3.36 |
| Q4 2025 | $2.73 | +$3.25 |
| Q3 2025 | $0.62 | +$1.48 |
| Q2 2025 | $0.43 | +$1.24 |
| Q1 2025 | -$0.40 | -148% |
| Q4 2024 | -$0.52 | -142% |
BMRC's earnings per share have jumped to their highest in seven years: $4.22 over the past year, up from $0.62 the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over BMRC on earnings, with more consistent year-over-year improvement.
BMRC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $35.1M | +13% |
| Q2 2026 | $34M | +230% |
| Q1 2026 | $34.1M | +23% |
| Q4 2025 | $79.3M | +183% |
| Q3 2025 | $30.9M | +14% |
| Q2 2025 | $10.3M | +181% |
| Q1 2025 | $27.8M | +9.3% |
| Q4 2024 | $28M | +33% |
BMRC has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 39% | +7.9 points |
| Q2 2026 | 37% | +146 points |
| Q1 2026 | 34% | +11 points |
| Q4 2025 | 59% | +25 points |
| Q3 2025 | 31% | +5.4 points |
| Q2 2025 | -109% | +830 points |
| Q1 2025 | 23% | +7.9 points |
| Q4 2024 | 34% | +33 points |
BMRC's operating margin was 39% last quarter, up 7.9 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over BMRC on profitability, with a higher operating margin.
BMRC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $16M | +33% |
| Q2 2026 | $11.8M | +68% |
| Q1 2026 | $921K | -80% |
| Q4 2025 | $13.2M | +25% |
| Q3 2025 | $12.1M | +24% |
| Q2 2025 | $7.1M | +111% |
| Q1 2025 | $4.6M | +11% |
| Q4 2024 | $10.6M | +1261% |
BMRC has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
BMRC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +49K shares |
| 1 year | +0.7% | +106K shares |
| 3 years | 0% | +4K shares |
| 5 years | +7% | +1M shares |
| Available history | +16% | +2.2M shares |
BMRC has 16M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $6,000 |
| Q1 2026 | $6,000 |
| Q4 2025 | — |
| Q3 2025 | $1.1M |
| Q4 2024 | $19,000 |
| Q2 2024 | $55,000 |
| Q4 2023 | — |
BMRC has spent almost nothing on buybacks in the past year.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over BMRC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
BMRC Net Leverage
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
BMRC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.3 | Neutral |
| Stochastic | 61.9 | Neutral |
BMRC's weekly RSI is 58 (neutral) and its Stochastic is 62 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
BMRC PE vs Financial Services Sector
| Metric | BMRC | Sector median | Relative |
|---|---|---|---|
| PE | 6.8x | 13x | 48% below |
| PE % | 6 | 63 | 57 pts below |
BMRC has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
BMRC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.6 | 3.2% above |
| 20 week MA | $27.9 | 2.1% above |
| 50 week MA | $26.9 | 6.1% above |
| 100 week MA | $25.1 | 13% above |
| 200 week MA | $22.6 | 26% above |
BMRC has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
BMRC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.0 | $36.5 | -21% |
| 2021 | $36.5 | $36.6 | +0.4% |
| 2022 | $36.6 | $33.0 | -9.9% |
| 2023 | $33.0 | $22.0 | -33% |
| 2024 | $22.0 | $23.5 | +6.8% |
| 2025 | $23.5 | $26.6 | +13% |
| 2026 YTD | $26.6 | $28.5 | +7.3% |
BMRC has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.